We did a comprehensive review of industry news in 2022Q1 (there was.. a lot of stuff to cover). In this article, we highlight some emerging companies, technologies, and drug discovery modalities we thought drug hunters would find interesting, including:
- New platform companies focused on drug discovery
- Different approaches to glues and degraders
- Strategies for targeting DNA, RNA, and other nucleic acids
- Interesting new cell therapy approaches
- Major pharma partnerships focused on new drug discovery modalities
Drug Discovery Platforms: 2022Q1 Update
request a trial
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
